–69 Pioglitazone, an agonist of PPARγ used in the treatment of type 2 diabetes mellitus, has been shown to significantly protect RGCs and prevent axonal degeneration in the glaucomatous retina of mice.70 Here, PPARG is linked to type 2 diabetes mellitus.